Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer

World Journal of Gastroenterology

Volumn 12, Issue 44, 2006, Pages 7104-7112

  Jazii, Ferdous Rastgar ^a   Najafi, Zahra ^a   Malekzadeh, Reza ^b   Conrads, Thomas P ^c   Ziaee, Abed Ali ^d   Abnet, Christian ^e   Yazdznbod, Mansour ^b   Karkhane, Ali Asghar ^a   Salekdeh, Ghasem H ^f  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SAIC FREDERICK INC   (United States)

^d UNIVERSITY OF TEHRAN   (Iran)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Agricultural Biotechnology Research Institute of Iran   (Iran)

Author keywords

Esophageal; Esophagus; Polypeptide marker; Proteomics; Squamous cell carcinoma; Two dimensional electrophoresis

Indexed keywords

BETA TROPOMYOSIN; CALRETICULIN; CONTRACTILE PROTEIN; HEAT SHOCK PROTEIN 70; ISOPROTEIN; KERATIN TYPE 1; LIPOCORTIN 1; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2; MYOSIN LIGHT POLYPEPTIDE 6; MYOSIN REGULATORY LIGHT CHAIN 2; ONCOPROTEIN; PEROXYREDOXIN 2; POLYPEPTIDE; TROPOMYOSIN; TROPOMYOSIN 4 ANAPLASTIC LEUKEMIA KINASE FUSION PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CANCER; FUNCTIONAL PROTEOMICS; HUMAN; HUMAN TISSUE; IMMUNODETECTION; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION;

EID: 33845419068     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i44.7104     Document Type: Article

References (57)

1. Gray JW, Collins C. Genome changes and gene expression in human solid tumors. Carcinogenesis 2000; 21: 443-452
2. Vogelstein B, Fearon ER, Hamilton SR, Kem SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532
3. Hondermarck H, Vercoutter-Edouart AS, Revillion F, Lemoine J, el-Yazidi-Belkoura I, Nurcombe V, Peyrat JP. Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 2001; 1: 1216-1232
4. Kim W, Oe Lim S, Kim JS, Ryu YH, Byeon JY, Kim HJ, Kim YI, Heo JS, Park YM, Jung G. Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma. Clin Cancer Res 2003; 9: 5493-5500
5. Anderson NG, Matheson A, Anderson NL. Back to the future: the human protein index (HPI) and the agenda for post-proteomic biology. Proteomics 2001; 1: 3-12
6. Srinivas PR, Verma. M, Zhao Y, Srivastava S. Proteomics for cancer biomarker discovery. Clin Chein 2002, 48: 1160-1169
7. Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994, 21: 403-410
8. Munoz N. Epidemiological aspects of oesophageal cancer. Endoscopy 1993; 25: 609-612
9. Rosen N. The molecular basis for cellular transformation: implications for esophageal carcinogenesis. Semin Oncol 1994; 21: 416-424
10. Sepehr A, Taniere P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, Etemad-Moghadam G, Kamangar F, Saidi F, Hainaut P. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene 2001; 20: 7368-7374
11. Rabilloud T, Vuillard L, Gilly C, Lawrence JJ. Silver-staining of proteins in polyacrylamide gets: a general overview. Cell Mol Biol 1994; 40: 57-75
12. Andrews AT. Electrophoresis, theory, techniques and biochemical and clinical applications. Oxford: Clarendon Press, 1990: 267-268
13. John E, Coligan Ada M, Kruisbeek David H, Margulies Ethan M, Shevach Warren Strober. Current Protocols in Immunology. New York. John Wiley and Sons, 1994: 1-6
14. 2 for enhanced peptide mass mapping by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2002; 16: 160-168
15. Paweletz CP, Ornstein DY, Roth W, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF 3rd. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 2000; 60: 6293-6297
16. Zhou G, Li H, DeCamp D, Chen S, Shu H, Gong Y, Flaig M, Gillespie JW, Hu N, Taylor PR, Emmert-Buck MR, Liotta LA, Petricoin EF 3rd, Zhao Y. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol Cell Proteomics 2002, 1: 117-124
17. Zhang LY, Ying WT, Mao YS, He HZ, Liu Y, Wang HX, Liu F, Wang K, Zhang DC, Wang Y, Wu M, Qian XH, Zhao XH. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol 2003; 9: 650-654
18. Xiong XD, Li EM, Xu LY, Chen HB, Chen L, Cai WJ, Han YL, Shen ZY, Zeng Y. Separation and identification of differentially expressed nuclear matrix proteins between human esophageal immortalized and carcinomatous cell lines. World J Gastroenterol 2003; 9: 2143-2148
19. Raval GN, Bharadwaj S, Levine EA, Willingham MC, Geary RL, Kute T, Prasad GL. Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors. Oncogene 2003; 22: 6194-6203
20. Kumar CC, Chang C. Human smooth muscle myosin light chain-2 gene expression is repressed in ras transformed fibroblast cells. Cell Growth Differ 1992; 3: 1-10
21. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004; 64: 9018-9026
22. Kageyama S, Isono T, Iwaki H, Wakabayashi Y, Okada Y, Kontani K, Yoshimura K, Terai A, Arai Y, Yoshild T. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chein 2004; 50: 857-866
23. Brunagel G, Shah U, Schoen RE, Getzenberg RH. Identification of calreticulin as a nuclear matrix protein associated with human colon cancer. J Cell Biochem 2003; 89: 238-243
24. Nishikawa J, Kiss C, Imai S, Takada K, Okita K, Klein G, Szekely L. Upregulation of the truncated basic hair keratin 1(hHb1-DeltaN) in carcinoma cells by Epstein-Barr virus (EBV). Int J Cancer 2003; 107: 597-602
25. He QY, Chen J, Kung HF, Yuen AP, Chiu JF. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004; 4: 271-278
26. Franzen B, Linder S, Uryu K, Alaiya AA, Hirano T, Kato H, Auer G. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer 1996; 73: 909-913
27. Prasad GL, Fuldner RA, Cooper HL. Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene. Proc Natl Acad Sci USA 1993; 90: 7039-7043
28. Shah V, Bharadwaj S, Kaibuchi K, Prasad GL. Cytoskeletal organization in tropomyosin-mediated reversion of rastransformation: Evidence for Rho kinase pathway. Oncogene 2001; 20: 2112-2121
29. Mahadev K, Raval G, Bharadwaj S, Willingham MC, Lange EM, Vonderhaar B, Salomon D, Prasad GL. Suppression of the transformed phenotype of breast cancer by tropomyosin-1. Exp Cell Res 2002; 279: 40-51
30. Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H, Helfman DM. A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell 2004; 15: 4682-4694
31. Janssen RA, Kim PN, Mier JW, Morrison DK. Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts. Mol Cell Biol 2003; 23: 1786-1797
32. Shields JM, Mehta H, Pruitt K, Der CJ. Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin. Mol Cell Biol 2002; 22: 2304-2317
33. Moskal TL, Huang S, Ellis LM, Fritsche HA Jr, Chakrabarty S. Serum levels of transforming growth factor alpha in gastrointestinal cancer patients. Cancer Epidemiol Biomarkers Prev 1995; 4: 127-131
34. Stoner GD, Gupta A. Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 2001; 22: 1737-1746
35. Vishwanatha JK, Salazar E, Gopalakrishnan VK. Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell lines. BMC Cancer 2004; 4: 8
36. Solito E, de Coupade C, Canaider S, Goulding NJ, Perretti M. Transfection. of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001; 133: 217-228
37. Xia SH, Hu LP, Hu H, Ying WT, Xu X, Cai Y, Han YL, Chen BS, Wei F, Qian XH, Cai YY, Shen Y, Wu M, Wang MR. Three isoforms of annexin I are preferentially expressed in normal esophageal epithelia but down-regulated in esophageal squamous cell carcinomas. Oncogene 2002; 21: 6641-6648
38. Liu SH, Lin CY, Peng SY, Jeng YM, Pan HW, Lai PL, Liu CL, Hsu HC. Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 2002; 160: 1831-1837
39. Pepinsky RB, Sinclair LK. Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 1986; 321: 81-84
40. Kang SW, Chae HZ, Seo MS, Kim K, Baines IC, Rhee SG. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha. J Biol Chem 1998; 273: 6297-6302
41. Kim H, Lee TH, Park ES, Suh JM, Park SJ, Chung HK, Kwon OY, Kim YK, Ro HK, Shong M. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chein 2000; 275: 18266-18270
42. Acharyya S, Ladner KJ, Nelsen LL, Damrauer J, Reiser PJ, Swoap S, Guttridge DC. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest 2004; 114: 370-378
43. Kaneko K, Satoh K, Masamune A, Satoh A, Shimosegawa T. Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines. Pancreas 2002; 24: 34-41
44. Samoszuk M, Tan J, Chorn G. Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts. Breast Cancer Res 2005; 7: R274-R283
45. Wang XP, Qiu FR, Liu GZ, Chen RF. Correlation between clinicopathology and expression of heat shock protein 70 and glucose-regulated protein 94 in human colonic adenocarcinoma. World J Gastroenterol 2005; 11: 1056-1059
46. Jaattela M, Wissing D, Kokholm K, Kallunki T, Egeblad M. Hsp70 exerts its anti-apoptotic function downstream of caspase-3-like proteases. EMBO J 1998; 17: 6124-6134
47. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 1997; 17: 5317-5327
48. Takashima M, Kuramitsu Y, Yokoyama Y, Iizuka N, Toda T, Sakaida I, Okita K, Oka M, Nakamura K. Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma. Proteomics 2003; 3: 2487-2493
49. Zhao ZG, Shen WL. Heat shock protein 70 antisense oligonucleotide inhibits cell growth and induces apoptosis in human gastric cancer cell line SGC-7901. World J Gastroenterol 2005; 11: 73-78
50. Rendon-Huerta E, Mendoza-Hernandez G, Robles-Flores M. Characterization of calreticulin as a protein interacting with protein kinase C. Biochem J 1999; 344 Pt 2: 469-475
51. Mesaeli N, Phillipson C. Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol Biol Cell 2004; 15: 1862-1870
52. Trask DY, Band V, Zajchowski DA, Yaswen P, Suh T, Sager R. Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc Natl Acad Sci USA 1990; 87: 2319-2323
53. Kinjo T, Kamiyama K, Chinen K, Iwamasa T, Kurihara K, Hamada T. Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol Pathol 2003; 56: 97-108
54. Yamamoto K, Oka M, Hayashi H, Tangoku A, Gondo T, Suzuki T. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 1997; 79: 1647-1655
55. Ladanyi M. Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms. Am J Pathol 2000; 157: 341-345
56. Lamant L, Dastugue N, Pulford K, Delsol G, Mariame B. A new fusion gene TPM3-ALK in anaphastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999; 93: 3088-3095
57. Lawrence B, Perez-Atayde A, Hibbard MY, Rubin BP, Dal Cin P, Pinkus JL, Pinkus GS, Xiac, S, Yi ES, Fletcher CD, Fletcher JA. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000; 157: 377-384